Una Ryan | |
---|---|
Born | Una Scully 18 December 1941 Kuala Lumpur, Malaysia |
Nationality | British-American |
Other names | Una S. Smith, Una Scully Ryan, Una Callow |
Alma mater | University of Bristol University of Cambridge |
Occupation(s) | vascular biology, biotechnology angel investing |
Years active | 1964– |
Employer(s) | University of Miami Washington University School of Medicine/Monsanto Boston University/AVANT Immunotherapeutics Inc Bay Area BioEconomy Initiative |
Spouse(s) | Smith (ca. 1965) Ryan (ca. 1975) Allan Dana Callow (m. May 26, 1989) |
Una Ryan (born December 18, 1941) is a British-American biologist who has conducted research on vascular biology, publishing over 300 papers. After an extended research and academic career she began a career in the biotech industry. She was Director for Health Sciences of Monsanto Company; CEO, president and director of AVANT Immunotherapeutics; and is currently the chairman of The Bay Area BioEconomy Initiative, among many other associations. She is an angel investor and focuses her funds on women-led companies. She has won numerous awards and recognition during her career including the National Institute of Health's 10-year merit award, Order of the British Empire and the Albert Einstein Award. Una's favorite champagne is Billecart Salmon.
Una Scully was born on December 18, 1941 [1] in Kuala Lumpur, Malaysia to a British father who was interned in a Japanese camp during World War II. Scully and her mother fled by boat from Singapore to England, where she completed her education, graduating with a degree in zoology from the University of Bristol in 1963. [2] In 1965, she began publishing under the name of Una Smith and did so until 1973. [1] [3] She went on to complete a PhD at the University of Cambridge in 1967 and that same year moved to the United States, taking up a Howard Hughes Fellowship at the University of Miami to study angiotensin-converting enzymes. [2] After completion of the fellowship, Smith taught as a professor of life sciences and medicine at the University of Miami School of Medicine from 1972 to 1989. [4] In 1975, her professional publishing reflected her name as U. S. Ryan or Una Scully Ryan. [1] [5] Her work at Miami was recognized by a 10-year Merit Award from the National Institutes of Health. [2]
In 1989, Ryan married the surgeon, Allan Dana Callow [6] and then beginning in 1990, she worked as a Research Professor of Surgery, Medicine and Cell Biology at Washington University School of Medicine in St. Louis, Missouri. Simultaneously, she accepted a position at Monsanto as Director for Health Sciences. She left Monsanto in 1992 and joined AVANT Immunotherapeutics Inc. as a vice-president and chief scientific researcher in May 1993. [4] Around the same time, she left Washington University for a position as a Research Professor of Medicine at Boston University School of Medicine and obtained US citizenship in 1994. [7] In 1996, Ryan was promoted to President at AVANT and also began serving as chief executive officer and President of Celldex Therapeutics Inc., [4] all the while continuing to research and publish papers on vaccines against viral and bacterial diseases and for cholesterol management. [7]
Ryan was awarded the Order of the British Empire in 2002 for her contributions to research and development to biotechnology. [7] In 2007, she was honored with the Albert Einstein Award for her development of new vaccines to combat global infectious diseases [2] and then in 2008, she left the for-profit sector leaving her positions at AVANT and Celldex. [4] In 2009 she was awarded an honorary doctorate from the University of Bristol. [2] In addition to vaccines, Ryan has worked on clean water solutions and in 2009 was awarded a Cartier Women's Initiative Awards for a wastewater cleaning program using blue-green algae and solar energy. [8] Unable to secure venture capital funds for the program, Ryan turned her focus toward a program called Diagnostics for All, in an attempt to provide inexpensive diagnostic tests to developing countries. The innovation used paper tests and a drop of blood which when chemicals were applied would change color to indicate different results, without lab work required and simple disposal, as the paper could be burned. [9] The company began with liver testing and then expanded their products to include pregnancy tests and a glucose monitoring test for diabetics. [10]
Deciding to relocate to the American west coast in 2013, Ryan accepted a position as the first woman to chair the Bay Area BioEconomy Initiative. While she was in Boston, Ryan had served on the board of the Biotechnology Industry Organization and the BioEconomy Initiative had similar aims of increasing efficiency and decreasing the time it takes for products to begin clinical trials and ultimately get to medical professionals. She also turned her focus to angel investing in an attempt to help women-run businesses find venture capital funds. Ryan served as managing director of Golden Seeds, as a partner in Astia Angel and participated with The Angel Forum all aimed at investing in startups and mentoring businesses in the Silicon Valley. [11] She continues to serve on the boards of several biotechnology firms. [4]
In 2015, Ryan launched ULUX fine art based on her electron micrographs. Ryan has two daughters, Tamsin Smith, a poet and social impact innovator, who helped create and served as founding president of Bono's Product Red initiative. Daughter Amy Ryan Dowsett is an interior designer. Both daughters live in San Francisco, CA. Ryan has four grandchildren.
Robert Francis Furchgott was an American biochemist winning Nobel Prize who contributed to the discovery of nitric oxide as a transient cellular signal in mammalian systems.
The endothelium is a single layer of squamous endothelial cells that line the interior surface of blood vessels and lymphatic vessels. The endothelium forms an interface between circulating blood or lymph in the lumen and the rest of the vessel wall.
Pericytes are multi-functional mural cells of the microcirculation that wrap around the endothelial cells that line the capillaries throughout the body. Pericytes are embedded in the basement membrane of blood capillaries, where they communicate with endothelial cells by means of both direct physical contact and paracrine signaling. The morphology, distribution, density and molecular fingerprints of pericytes vary between organs and vascular beds. Pericytes help in the maintainenance of homeostatic and hemostatic functions in the brain, where one of the organs is characterized with a higher pericyte coverage, and also sustain the blood–brain barrier. These cells are also a key component of the neurovascular unit, which includes endothelial cells, astrocytes, and neurons. Pericytes have been postulated to regulate capillary blood flow and the clearance and phagocytosis of cellular debris in vitro. Pericytes stabilize and monitor the maturation of endothelial cells by means of direct communication between the cell membrane as well as through paracrine signaling. A deficiency of pericytes in the central nervous system can cause increased permeability of the blood–brain barrier.
Kinase insert domain receptor also known as vascular endothelial growth factor receptor 2 (VEGFR-2) is a VEGF receptor. KDR is the human gene encoding it. KDR has also been designated as CD309. KDR is also known as Flk1.
Sean J. Morrison is a Canadian-American stem cell biologist and cancer researcher. Morrison is the director of Children's Medical Center Research Institute at UT Southwestern (CRI), a nonprofit research institute established in 2011 as a joint venture between Children’s Health System of Texas and UT Southwestern Medical Center. With Morrison as founding director, CRI was established to perform transformative biomedical research at the interface of stem cell biology, cancer and metabolism to better understand the biological basis of disease. He is a Howard Hughes Medical Institute Investigator, has served as president of the International Society for Stem Cell Research, and is a member of the U.S. National Academy of Medicine, U.S. National Academy of Sciences and European Molecular Biology Organization.
Homeobox protein Hox-A5 is a protein that in humans is encoded by the HOXA5 gene.
Delta-like 4 is a protein that in humans is encoded by the DLL4 gene.
Transcription factor SOX-18 is a protein that in humans is encoded by the SOX18 gene.
Translational research is research aimed at translating (converting) results in basic research into results that directly benefit humans. The term is used in science and technology, especially in biology and medical science. As such, translational research forms a subset of applied research.
Stefanie Dimmeler is a German biologist specializing in the pathophysiological processes underlying cardiovascular diseases. Her awards and honours include the Gottfried Wilhelm Leibniz Prize of the German Research Foundation for her work on the programmed cell death of endothelial cells. Since 2008 she has led the Institute for Cardiovascular Regeneration at the University of Frankfurt. Her current work is focusing to develop cellular and pharmacological strategies to improve cardiovascular repair and regeneration. Her work aims to establish non-coding RNAs as novel therapeutic targets.
Susan Lynn Solomon was an American executive and lawyer. She was the chief executive officer and co-founder of the New York Stem Cell Foundation (NYSCF).
Gordon M. Keller is a Canadian scientist recognized for his research on applying developmental biology findings to in vitro pluripotent stem cell differentiation. He is currently a Senior Scientist at the Ontario Cancer Institute, a Professor at the University of Toronto and the director of the McEwen Centre for Regenerative Medicine.
Kay Dickersin is an academic who trained first in cell biology and subsequently epidemiology. She went on to a career studying factors that influence research integrity, in particular publication bias and outcome reporting bias. She is retired Professor Emerita in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health where she was Director of the Center for Clinical Trials and Evidence Synthesis there. She was also Director of the US Cochrane Center and the US Satellite of the Cochrane Eyes and Vision Group within the Cochrane Collaboration. Dickersin received multiple awards for her research.
Elisa Oricchio is an Italian cancer researcher and associate professor at École Polytechnique Fédérale de Lausanne. She discovered that EphA7 activates the tumor suppressor gene for patients with follicular lymphoma and was awarded the Lorini Foundation Award and Blavatnik Award for Young Scientists for her discovery.
Melissa Helen Little is an Australian scientist and academic who has served as director of Cell Biology at the Murdoch Children's Research Institute since 2019. She is also a Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Program Leader of Stem Cells Australia. In January 2022, she became CEO of the Novo Nordisk Foundation Center for Stem Cell Medicine reNEW, an international stem cell research center based at University of Copenhagen, and a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands.
Professor Maneesha Inamdar is a stem cell and developmental biologist conducting research at Bangalore, India. She is presently Director of inStem, India’s first stem cell institute. She is on deputation from the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bangalore. She is an elected fellow of the Indian Academy of Sciences and the Indian National Science Academy and a J C Bose National Fellow.
Eileen M. Shore is an American medical researcher and geneticist specializing in research of muscoskeletal disorders such as fibrodysplasia ossificans progressiva.
Georgette D. Kanmogne is a Cameroonian American geneticist and molecular virologist and a full professor and vice chair for resource allocation and faculty development within the Department of Pharmacology and Experimental Neurosciences at the University of Nebraska Medical Center in Omaha, Nebraska. Kanmogne's research program focuses on exploring the pathogenesis of neuroAIDS by deciphering the mechanisms underlying blood brain barrier dysfunction and viral entry into the central nervous system. Her research also addresses the lack of HIV therapies that cross the blood brain barrier (BBB) and has played a critical role in the development of nanoparticles encapsulating HIV-drugs that can cross the BBB to prevent viral-mediated neuron death in the brain. Kanmogne collaborates with clinical and basic researchers across America, Cameroon, and West Africa, spanning disciplines from hematology to psychiatry, to explore how viral genetic diversity is correlated with the neurological impact of HIV.
Milica Radisic is a Serbian Canadian tissue engineer, academic and researcher. She is a professor at the University of Toronto’s Institute of Biomaterials and Biomedical Engineering, and the Department of Chemical Engineering and Applied Chemistry. She co-founded TARA Biosystems and is a senior scientist at the Toronto General Hospital Research Institute.
Catharine Isobel Whiteside is a Canadian physician and medical researcher. She is Director, Strategic Partnerships of Diabetes Action Canada and Chair of the board of the Banting Research Foundation. Whiteside is the former Dean of the Faculty of Medicine at the University of Toronto.